| 1. |
Wang Y, Wang X, Xi L, et al. Advancements in diagnosing Talaromycosis: exploring novel strategies and emerging technologies. J Fungi (Basel), 2025, 11(6): 434.
|
| 2. |
何海洋, 薛瀟春, 潘煒華, 等. HIV陰性馬爾尼菲籃狀菌病研究進展. 菌物學報, 2024, 43(10): 4-14.
|
| 3. |
Qiu Y, Liao H, Zhang J, et al. Differences in clinical characteristics and prognosis of Penicilliosis among HIV-negative patients with or without underlying disease in Southern China: a retrospective study. BMC Infect Dis, 2015, 15: 525.
|
| 4. |
Qiu Y, Zhang J, Liu G, et al. Retrospective analysis of 14 cases of disseminated Penicillium marneffei infection with osteolytic lesions. BMC Infect Dis, 2015, 15: 47.
|
| 5. |
Cao C, Xi L, Chaturvedi V. Talaromycosis (Penicilliosis) due to Talaromyces (Penicillium) marneffei: insights into the clinical trends of a major fungal disease 60 years after the discovery of the pathogen. Mycopathologia, 2019, 184(6): 709-720.
|
| 6. |
中華醫學會感染病學分會艾滋病學組, 中國疾病預防控制中心. 中國艾滋病診療指南(2024版). 中華臨床感染病雜志, 2024, 17(3): 161-190.
|
| 7. |
Browne SK, Burbelo PD, Chetchotisakd P, et al. Adult-onset immunodeficiency in Thailand and Taiwan. N Engl J Med, 2012, 367(8): 725-734.
|
| 8. |
Browne SK, Zaman R, Sampaio EP, et al. Anti-CD20 (rituximab) therapy for anti-IFN-γ autoantibody-associated nontuberculous mycobacterial infection. Blood, 2012, 119(17): 3933-3939.
|
| 9. |
Rello J, Allam C, Ruiz-Spinelli A, et al. Severe Legionnaires' disease. Ann Intensive Care, 2024, 14(1): 51.
|
| 10. |
Wipasa J, Chaiwarith R, Chawansuntati K, et al. Characterization of anti-interferon-γ antibodies in HIV-negative immunodeficient patients infected with unusual intracellular microorganisms. Exp Biol Med (Maywood), 2018, 243(7): 621-626.
|
| 11. |
Guo J, Ning XQ, Ding JY, et al. Anti-IFN-γ autoantibodies underlie disseminated Talaromyces marneffei infections. J Exp Med, 2020, 217(12): e20190502.
|
| 12. |
Ku CL, Lin CH, Chang SW, et al. Anti-IFN-γ autoantibodies are strongly associated with HLA-DR*15: 02/16: 02 and HLA-DQ*05: 01/05: 02 across Southeast Asia. J Allergy Clin Immunol, 2016, 137(3): 945-948,e8.
|
| 13. |
Krisnawati DI, Liu YC, Lee YJ, et al. Functional neutralization of anti-IFN-γ autoantibody in patients with nontuberculous mycobacteria infection. Sci Rep, 2019, 9(1): 5682.
|
| 14. |
Chetchotisakd P, Anunnatsiri S, Nanagara R, et al. Intravenous cyclophosphamide therapy for anti-IFN-gamma autoantibody-associated mycobacterium abscessus infection. J Immunol Res, 2018, 2018: 6473629.
|
